+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Bioactive Wound Management - Global Market Trajectory & Analytics

  • ID: 5309889
  • Report
  • February 2022
  • Region: Global
  • 403 Pages
  • Global Industry Analysts, Inc

Global Bioactive Wound Management Market to Reach US$2.5 Billion by the Year 2026


Bioactive dressings refer to dressings made using natural resources that find application in managing both chronic and acute wounds. They contain bioactive substances that remain active during the process of wound healing. The global bioactive wound management market is growing led by factors including an ageing population, growing prevalence of tissue disorders, and escalating cases of chronic wounds. The growing prevalence of lifestyle associated disorders, especially diabetes is giving rise to diabetic foot ulcers, pressure ulcers, and venous leg ulcers. The number of people (adults aged between 20-79 years) with diabetes is expected to grow from about 463 million in 2019 to reach 700 million by 2045. These numbers also indicate the ratio of those suffering from Type II diabetes to increase in most countries. Overall, these growing cases represent opportunities and undeterred growth for global bioactive wound care management market in the coming years. At the same time, skin injuries and wound infection are also key factors driving demand for bioactive wound care management. Meanwhile, wound infection is one of the key concerns for both healthcare providers and patients across the world, and the need for effective care and management for lowering infection makes way for bioactive wound care management solutions. The market already offers technologically advanced products such as occlusive dressings for skin injuries that allow a moist environment to be maintained for promoting active healing, and keratin-based products that when used together with injury dressings allow re-epithelialization of damaged skin tissue.

Amid the COVID-19 crisis, the global market for Bioactive Wound Management estimated at US$1.6 Billion in the year 2020, is projected to reach a revised size of US$2.5 Billion by 2026, growing at a CAGR of 7.8% over the analysis period. Alginates, one of the segments analyzed in the report, is projected to grow at a 6.8% CAGR to reach US$826.1 Million by the end of the analysis period. After a thorough analysis of the business implications of the pandemic and its induced economic crisis, growth in the Collagen-Based Dressings segment is readjusted to a revised 9.1% CAGR for the next 7-year period. This segment currently accounts for a 23.9% share of the global Bioactive Wound Management market. Alginate dressing is made using highly absorbent materials to promote wound healing. This dressing finds use in exudant wounds where excess fluid is present. A key trend in the advanced wound care market is the emergence of combination dressings which are prepared using various available products of wound dressings in several different combinations, most generally including a biological agent and an antimicrobial material. Collagen and foam dressings, collagen hydrocolloid dressings, silver collagen dressings, and silver alginate dressings are some of the combination dressings that are being used for the treatment of chronic wounds.



The U.S. Market is Estimated at $650.9 Million in 2021, While China is Forecast to Reach $211.3 Million by 2026


The Bioactive Wound Management market in the U.S. is estimated at US$650.9 Million in the year 2021. The country currently accounts for a 38.66% share in the global market. China, the world`s second largest economy, is forecast to reach an estimated market size of US$211.3 Million in the year 2026 trailing a CAGR of 9.8% through the analysis period. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 6.4% and 6.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 7.5% CAGR while Rest of European market (as defined in the study) will reach US$220.8 Million by the end of the analysis period. North America has emerged as a leading global market for advanced wound care management technologies such as bioactive wound care dressings. The regional market benefits from a rapidly expanding base of ageing population, a sizeable diabetic population, and higher prevalence of chronic diseases. The Asia-Pacific market for bioactive wound management is fast growing owing to an expanding diabetic population, with increased incidence of infections, pressure ulcers and diabetic foot among others.

Antimicrobial Dressings Segment to Reach $434 Million by 2026


Antimicrobial dressings are wound dressings that include an antiseptic agent that helps destroy microorganisms present in the wound. These dressings are mainly used for wounds that fail to heal due to increasing bacterial load, and for wounds that have a high risk of infection. Rise in demand for these dressings is also due to the growing need to reduce hospital acquired infections, and rising prevalence of bacteria which is resistant to antibiotics. In the global Antimicrobial Dressings segment, USA, Canada, Japan, China and Europe will drive the 6.1% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$248.1 Million in the year 2020 will reach a projected size of US$377.5 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$27.8 Million by the year 2026.

Select Competitors (Total 90 Featured) -

  • 3M Company
  • B. Braun Melsungen AG
  • Coloplast A/S
  • ConvaTec Group plc
  • Covalon Technologies Ltd.
  • DermaRite Industries, LLC
  • ETS Wound Care, LLC
  • Hartmann USA, Inc.
  • Hollister Incorporated
  • Integra LifeSciences Holdings Corporation
  • Johnson & Johnson Services, Inc.
  • Medtronic PLC
  • MiMedx Group
  • Mölnlycke Health Care AB
  • Organogenesis Inc.
  • Smith & Nephew PLC
Frequently Asked Questions about the Global Market for Bioactive Wound Management

What is the estimated value of the Global Market for Bioactive Wound Management?

The Global Market for Bioactive Wound Management was estimated to be valued at $1.6 Billion in 2020.

What is the growth rate of the Global Market for Bioactive Wound Management?

The growth rate of the Global Market for Bioactive Wound Management is 7.7%, with an estimated value of $2.5 Billion by 2026.

What is the forecasted size of the Global Market for Bioactive Wound Management?

The Global Market for Bioactive Wound Management is estimated to be worth $2.5 Billion by 2026.

Who are the key companies in the Global Market for Bioactive Wound Management?

Key companies in the Global Market for Bioactive Wound Management include 3M Company, B. Braun Melsungen AG, Coloplast A/S, ConvaTec Group plc, Covalon Technologies Ltd., DermaRite Industries, LLC, ETS Wound Care, LLC, Hartmann USA, Inc. and Integra LifeSciences Holdings Corporation.

Table of Contents

I. METHODOLOGY


II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Impact of Covid-19 and a Looming Global Recession
  • 2020: A Year of Disruption & Transformation
  • As the Race between the Virus & Vaccines Intensifies, Review of the World Economy in 2021
  • World Economic Growth Projections (Real GDP, Annual % Change) for 2020 through 2022
  • COVID-19-Led Wound Management Crisis & Patient Suffering Create Need for Effective Interventions
  • Dwindling Revenues for Wound Care Practices
  • Telemedicine, Remote Patient Monitoring Takes Center Stage
  • Influencer Market Insights
  • World Market Trajectories
  • Bioactive Wound Management – Global Key Competitors Percentage Market Share in 2022 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
  • Wounds & Wound Management: A Prelude
  • Bioactive Wound Management: A Prelude
  • Outlook
  • Healthcare Burden of Chronic Wounds and the Need for Effective Wound Management Products
  • Prevalence and Incidence of Wounds – Select Statistics
  • Global Prevalence of Wounds by Type (in Millions)
  • Global Wound Care Market: Percentage Breakdown of Spending by Wound Type
  • Healing Time by Type of Wound (in Days)
  • Chronic Wounds: Select Statistics
  • Reduced Economic Cost of Wound Care Triggers Transition to Advanced Products
  • Breakdown of Costs Associated with Wound Care
  • Recent Market Activity

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

  • Effective Burn Wound Management with Bioactive Dressings
  • Uptrend in Surgical Care Augurs Well for Market Growth
  • Global Surgical Procedure Volume by Procedure Type
  • Rise in Prevalence of Pressure Ulcers and the Growing Focus on Treatment Solutions
  • Pressure Ulcer Occurrence Rate Based on the Length of Surgery
  • Understanding the Wound: A Widening Area of Interest
  • Smart” Dressings Set the Road to Futuristic Wound Care
  • Startups Enter the Fray
  • Growing Focus on Reducing Hospital Stays Lends Traction
  • Technological Advancements Remain Buoyant
  • Conductive Bio-material Wound Dressings Beneficial for Wound Healing
  • Combination Dressings Emerge as a Key Trend
  • Cellulose-based Dressings Exude Immense Potential for Chronic Wound Management
  • 3D-Printed Stem Cells & Lasers to Kill Bacteria
  • New Bioactive Wound Dressings
  • Chitin, Chitosan and Derivatives
  • Bioactive Glasses Show Promising Wound Healing Outcomes
  • Rising Incidence of Diabetes and DFUs to Propel Market Growth
  • World Diabetes and Population Statistics (2019, 2030 & 2045)
  • Global Diabetes Mellitus Population Breakdown by Geographic Region: 2019, 2030 and 2045
  • World Diabetes Prevalence (2000 - 2019)
  • COVID-19 Crisis & Restrictions Upend Care for Diabetic Foot Disease Patients
  • Growing Acceptance of Moist Wound Environment Spurs Demand for Moist Wound Dressings
  • Alginate Dressings Dominate the Market
  • Antimicrobial Dressings Find Application for Healing Wounds with High Bacterial Load
  • Multi-Drug Resistant Bacteria: A Pressing Concern
  • Tissue Engineering in Wound Care
  • Bioengineered Skin Substitutes
  • Collagen Dressings in Advanced Wound Care
  • MACRO GROWTH DRIVERS
  • Impact of Healthcare Expenditure on Market Growth
  • World Healthcare Expenditure (In US$ Billion) for the Years 2017-2023
  • Elderly Healthcare Expenditure as a % of GDP for 1970, 2010 and 2050
  • Expanding Aging Population Spurs Demand
  • Global Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
  • Growing Obesity Levels Fuel Demand
  • Global Obesity Epidemic: Percentage of Overweight, Obese, and Severely Obese Adults for 2014 & 2025

4. GLOBAL MARKET PERSPECTIVE


III. MARKET ANALYSIS

UNITED STATES

  • Bioactive Wound Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2022 (E)

CANADA

JAPAN

  • Bioactive Wound Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2022 (E)

CHINA

  • Bioactive Wound Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2022 (E)

EUROPE

  • Bioactive Wound Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2022 (E)

FRANCE

  • Bioactive Wound Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2022 (E)

GERMANY

  • Bioactive Wound Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2022 (E)

ITALY

UNITED KINGDOM

  • Bioactive Wound Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2022 (E)

REST OF EUROPE

ASIA-PACIFIC

  • Bioactive Wound Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2022 (E)

REST OF WORLD

IV. COMPETITION

  • Total Companies Profiled: 90

Companies Mentioned

A selection of companies mentioned in this report includes:

  • 3M Company
  • B. Braun Melsungen AG
  • Coloplast A/S
  • ConvaTec Group plc
  • Covalon Technologies Ltd.
  • DermaRite Industries, LLC
  • ETS Wound Care, LLC
  • Hartmann USA, Inc.
  • Hollister Incorporated
  • Integra LifeSciences Holdings Corporation
  • Johnson & Johnson Services, Inc.
  • Medtronic PLC
  • MiMedx Group
  • Mölnlycke Health Care AB
  • Organogenesis Inc.
  • Smith & Nephew PLC